Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Regulatory & Reimbursement

Pathways' Picks June 9: China AI Guide, IVDR Plan, and More To Watch

In this week’s roundup: digital health updates including a draft guidance on artificial intelligence devices in China and a new FDA-adjacent Collaborative Community; a new all-hands-on-deck plan for EU IVDR implementation and more EU regulatory news; an updated guidance on device advertising in Saudi Arabia; more from China, Australia, and the US.

Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Business Strategies

Stereotaxis’ Second Act

A pioneer in endovascular robotics, Stereotaxis hit a wall just over a decade ago and was near extinction soon after. Now, with a new CEO in place, is the company finally poised to realize the potential of its technology?

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More